These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15218725)

  • 1. [Initial experience with protocol biopsies in transplanted kidneys].
    Matl I; Viklický O; Voska L; Lácha J; Teplan V; Vítko S
    Cas Lek Cesk; 2004; 143(4):253-6. PubMed ID: 15218725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Subclinical acute rejections in protocol biopsies at 3 months after kidney transplantation].
    Matl I; Honsová E; Lodererová A; Lánská V; Viklický O
    Vnitr Lek; 2008 Nov; 54(11):1054-8. PubMed ID: 19069678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus as secondary intervention vs. cyclosporine continuation in patients at risk for chronic renal allograft failure.
    Waid T;
    Clin Transplant; 2005 Oct; 19(5):573-80. PubMed ID: 16146546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and immunohistochemical findings of subclinical kidney allograft rejection and its association with graft outcome.
    Veronese FV; Noronha IL; Manfro RC; Edelweiss MI; Goldberg J; Gonçalves LF
    Clin Transplant; 2004 Aug; 18(4):357-64. PubMed ID: 15233810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathologic evaluation of pretransplant biopsy as a factor influencing graft function after kidney transplantation: a 1-year observation.
    Sulikowski T; Tejchman K; Domański L; Urasińska E; Kamiński M; Zietek Z; Sieńko J; Romanowski M; Safranow K; Bohatyrewicz R; Ciechanowski K; Ostrowski M
    Transplant Proc; 2007 May; 39(4):943-7. PubMed ID: 17524858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of different immunosuppressive regimens on TGF-beta1 expression in kidney transplant patients.
    Matl I; Viklický O; Voska L; Lodererová A; Vítko S
    Transpl Int; 2005 Jun; 18(6):668-71. PubMed ID: 15910291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Untreated rejection in 6-month protocol biopsies is not associated with fibrosis in serial biopsies or with loss of graft function.
    Scholten EM; Rowshani AT; Cremers S; Bemelman FJ; Eikmans M; van Kan E; Mallat MJ; Florquin S; Surachno J; ten Berge IJ; Bajema IM; de Fijter JW
    J Am Soc Nephrol; 2006 Sep; 17(9):2622-32. PubMed ID: 16899517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential predictive markers in protocol biopsies for premature renal graft loss.
    Matl I; Hribova P; Honsova E; Brabcova I; Viklicky O
    Kidney Blood Press Res; 2010; 33(1):7-14. PubMed ID: 20090361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No difference in degree of interstitial Sirius red-stained area in serial biopsies from area under concentration-over-time curves-guided cyclosporine versus tacrolimus-treated renal transplant recipients at one year.
    Rowshani AT; Scholten EM; Bemelman F; Eikmans M; Idu M; Roos-van Groningen MC; Surachno JS; Mallat MJ; Paul LC; de Fijter JW; Bajema IM; ten Berge I; Florquin S
    J Am Soc Nephrol; 2006 Jan; 17(1):305-12. PubMed ID: 16306168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of subclinical renal allograft rejection by vascular endothelial growth factor in serum and urine.
    Peng W; Chen J; Jiang Y; Shou Z; Chen Y; Wang H
    J Nephrol; 2008; 21(4):535-42. PubMed ID: 18651543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Timing and value of protocol biopsies in well-matched kidney transplant recipients--a clinical and histopathologic analysis.
    Helanterä I; Ortiz F; Helin H; Räisänen-Sokolowski A; Honkanen E; Koskinen P
    Transpl Int; 2007 Nov; 20(11):982-90. PubMed ID: 17711407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized prospective trial of early steroid withdrawal compared with low-dose steroids in renal transplant recipients using serial protocol biopsies to assess efficacy and safety.
    Laftavi MR; Stephan R; Stefanick B; Kohli R; Dagher F; Applegate M; O'Keefe J; Pierce D; Rubino A; Guzowski H; Leca N; Dayton M; Pankewycz O
    Surgery; 2005 Mar; 137(3):364-71. PubMed ID: 15746793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
    Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
    Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical factors associated with graft fibrosis in kidney-transplant recipients on steroid-avoidance immunosuppression.
    Heilman RL; Chakkera HA; Reddy KS; Colby TV; Moss AA; Williams JW; Mazur MJ; Petrides S; Mulligan DC
    Clin Transplant; 2008; 22(3):309-15. PubMed ID: 18482051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-year routine renal transplant biopsies in children.
    Benamenyo JP; Droz D; Niaudet P
    Pediatr Nephrol; 2001 Dec; 16(12):971-7. PubMed ID: 11793082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rejection after simultaneous pancreas-kidney transplantation.
    Arbogast H; Malaise J; Illner WD; Tarabichi A; Dieterle C; Landgraf R; Land W;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii11-7, ii62. PubMed ID: 15814544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-year study of tacrolimus as secondary intervention versus continuation of cyclosporine in renal transplant patients at risk for chronic renal allograft failure.
    Jevnikar A; Arlen D; Barrett B; Boucher A; Cardella C; Cockfield SM; Rush D; Paraskevas S; Shapiro J; Shoker A; Yilmaz S; Zaltzman JS; Kiberd B
    Transplantation; 2008 Oct; 86(7):953-60. PubMed ID: 18852662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.